Progyny Statistics
Total Valuation
Progyny has a market cap or net worth of $1.82 billion. The enterprise value is $1.77 billion.
Important Dates
The last earnings date was Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Progyny has 85.67 million shares outstanding. The number of shares has decreased by -8.31% in one year.
| Current Share Class | 85.67M |
| Shares Outstanding | 85.67M |
| Shares Change (YoY) | -8.31% |
| Shares Change (QoQ) | +0.44% |
| Owned by Insiders (%) | 1.43% |
| Owned by Institutions (%) | 90.30% |
| Float | 72.46M |
Valuation Ratios
The trailing PE ratio is 37.40 and the forward PE ratio is 12.87. Progyny's PEG ratio is 1.69.
| PE Ratio | 37.40 |
| Forward PE | 12.87 |
| PS Ratio | 1.71 |
| Forward PS | 1.64 |
| PB Ratio | 4.29 |
| P/TBV Ratio | 4.54 |
| P/FCF Ratio | 10.23 |
| P/OCF Ratio | 9.85 |
| PEG Ratio | 1.69 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 23.11, with an EV/FCF ratio of 9.05.
| EV / Earnings | 33.75 |
| EV / Sales | 1.46 |
| EV / EBITDA | 23.11 |
| EV / EBIT | 24.24 |
| EV / FCF | 9.05 |
Financial Position
The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.06.
| Current Ratio | 2.39 |
| Quick Ratio | 2.34 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.33 |
| Debt / FCF | 0.13 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 10.11% and return on invested capital (ROIC) is 8.43%.
| Return on Equity (ROE) | 10.11% |
| Return on Assets (ROA) | 5.99% |
| Return on Invested Capital (ROIC) | 8.43% |
| Return on Capital Employed (ROCE) | 14.82% |
| Revenue Per Employee | $1.78M |
| Profits Per Employee | $77,201 |
| Employee Count | 680 |
| Asset Turnover | 1.59 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Progyny has paid $34.73 million in taxes.
| Income Tax | 34.73M |
| Effective Tax Rate | 39.81% |
Stock Price Statistics
The stock price has decreased by -34.11% in the last 52 weeks. The beta is 1.38, so Progyny's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | -34.11% |
| 50-Day Moving Average | 21.96 |
| 200-Day Moving Average | 19.98 |
| Relative Strength Index (RSI) | 37.06 |
| Average Volume (20 Days) | 1,063,738 |
Short Selling Information
The latest short interest is 6.51 million, so 7.60% of the outstanding shares have been sold short.
| Short Interest | 6.51M |
| Short Previous Month | 6.45M |
| Short % of Shares Out | 7.60% |
| Short % of Float | 8.99% |
| Short Ratio (days to cover) | 4.09 |
Income Statement
In the last 12 months, Progyny had revenue of $1.21 billion and earned $52.50 million in profits. Earnings per share was $0.57.
| Revenue | 1.21B |
| Gross Profit | 266.75M |
| Operating Income | 73.10M |
| Pretax Income | 84.78M |
| Net Income | 52.50M |
| EBITDA | 76.67M |
| EBIT | 73.10M |
| Earnings Per Share (EPS) | $0.57 |
Full Income StatementBalance Sheet
The company has $256.12 million in cash and $26.00 million in debt, giving a net cash position of $230.13 million or $2.69 per share.
| Cash & Cash Equivalents | 256.12M |
| Total Debt | 26.00M |
| Net Cash | 230.13M |
| Net Cash Per Share | $2.69 |
| Equity (Book Value) | 467.16M |
| Book Value Per Share | 5.45 |
| Working Capital | 330.56M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $203.18 million and capital expenditures -$7.40 million, giving a free cash flow of $195.78 million.
| Operating Cash Flow | 203.18M |
| Capital Expenditures | -7.40M |
| Free Cash Flow | 195.78M |
| FCF Per Share | $2.29 |
Full Cash Flow StatementMargins
Gross margin is 21.99%, with operating and profit margins of 6.03% and 4.33%.
| Gross Margin | 21.99% |
| Operating Margin | 6.03% |
| Pretax Margin | 7.19% |
| Profit Margin | 4.33% |
| EBITDA Margin | 6.32% |
| EBIT Margin | 6.03% |
| FCF Margin | 16.14% |